Reviewing Innovative Eyewear (LUCY) & Its Rivals

Innovative Eyewear (NASDAQ:LUCY – Get Free Report) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it weigh in compared to its peers? We will compare Innovative Eyewear to related companies based on the strength of its risk, profitability, earnings, institutional ownership, dividends, analyst recommendations and valuation.

Risk & Volatility

Innovative Eyewear has a beta of 2.75, meaning that its share price is 175% more volatile than the S&P 500. Comparatively, Innovative Eyewear’s peers have a beta of 2.57, meaning that their average share price is 157% more volatile than the S&P 500.

Insider & Institutional Ownership

1.0% of Innovative Eyewear shares are held by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are held by institutional investors. 1.8% of Innovative Eyewear shares are held by company insiders. Comparatively, 14.8% of shares of all “Healthcare Equipment & Supplies” companies are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Valuation and Earnings

This table compares Innovative Eyewear and its peers top-line revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Innovative Eyewear $2.66 million -$7.59 million -0.64
Innovative Eyewear Competitors $1.89 billion $138.76 million 9.95

Innovative Eyewear’s peers have higher revenue and earnings than Innovative Eyewear. Innovative Eyewear is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Analyst Recommendations

This is a breakdown of current recommendations for Innovative Eyewear and its peers, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Innovative Eyewear 1 1 0 0 1.50
Innovative Eyewear Competitors 4266 10522 18282 825 2.46

As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 19.33%. Given Innovative Eyewear’s peers stronger consensus rating and higher possible upside, analysts plainly believe Innovative Eyewear has less favorable growth aspects than its peers.

Profitability

This table compares Innovative Eyewear and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Innovative Eyewear -225.26% -88.90% -80.34%
Innovative Eyewear Competitors -276.78% -149.08% -21.73%

Summary

Innovative Eyewear peers beat Innovative Eyewear on 9 of the 12 factors compared.

Innovative Eyewear Company Profile

(Get Free Report)

Innovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses. The company's flagship product is Lucyd Lyte glasses that enable the wearer to listen to music, take and make calls, and use voice assistants to perform various smartphone tasks hands-free. It also offers Vyrb, a social media application that enables the user to receive and send posts through Lucyd Lyte smart glasses with voice. In addition, the company launches an application, Lucyd app for iOS/Android users. It sells its products through various e-commerce, and retail store and distribution channels. Innovative Eyewear, Inc. has a license agreement with Lucyd Ltd. The company was incorporated in 2019 and is headquartered in North Miami, Florida. Innovative Eyewear, Inc. is a subsidiary of Lucyd Ltd.

Receive News & Ratings for Innovative Eyewear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovative Eyewear and related companies with MarketBeat.com's FREE daily email newsletter.